Brief: MyMD Pharmaceuticals Advances Phase 2 Multi-Center Clinical Trial Of MYMD-1 As Therapy For Delaying Aging And Extending Healthy Lifespan
26/07/2022 12:42
July 26 (Reuters) - MyMD Pharmaceuticals Inc MYMD.O :
* MYMD PHARMACEUTICALS® ADVANCES PHASE 2 MULTI-CENTER
CLINICAL
TRIAL OF MYMD-1® AS A THERAPY FOR DELAYING AGING AND EXTENDING
HEALTHY LIFESPAN
* MYMD PHARMACEUTICALS - SARCOPENIA TRIAL SHOWS NO EVIDENCE
OF
TOXICITY OR SAFETY ISSUES AND PATIENTS WERE ENROLLED IN NEXT
HIGHER DOSE OF MYMD-1
Source text for Eikon: ID:nBw87Y8pSa
Further company coverage: MYMD.O
((Reuters.Briefs@thomsonreuters.com;))